1. Home
  2. PRIM vs RGEN Comparison

PRIM vs RGEN Comparison

Compare PRIM & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Primoris Services Corporation

PRIM

Primoris Services Corporation

N/A

Current Price

$133.94

Market Cap

6.8B

Sector

Industrials

ML Signal

N/A

Logo Repligen Corporation

RGEN

Repligen Corporation

N/A

Current Price

$121.61

Market Cap

8.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PRIM
RGEN
Founded
1960
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Water Sewer Pipeline Comm & Power Line Construction
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
8.1B
IPO Year
2006
1995

Fundamental Metrics

Financial Performance
Metric
PRIM
RGEN
Price
$133.94
$121.61
Analyst Decision
Buy
Buy
Analyst Count
15
11
Target Price
$153.13
$173.09
AVG Volume (30 Days)
669.8K
767.3K
Earning Date
05-26-2026
05-27-2026
Dividend Yield
0.24%
N/A
EPS Growth
51.66
286.96
EPS
5.02
0.86
Revenue
N/A
$141,236,000.00
Revenue This Year
$8.56
$14.11
Revenue Next Year
$8.99
$14.71
P/E Ratio
$26.56
$139.37
Revenue Growth
N/A
35.10
52 Week Low
$49.67
$102.97
52 Week High
$174.43
$175.77

Technical Indicators

Market Signals
Indicator
PRIM
RGEN
Relative Strength Index (RSI) 35.79 33.82
Support Level $123.74 $121.25
Resistance Level $142.51 $132.51
Average True Range (ATR) 7.83 6.58
MACD -3.36 -0.05
Stochastic Oscillator 8.82 15.23

Price Performance

Historical Comparison
PRIM
RGEN

About PRIM Primoris Services Corporation

Primoris Services Corp is a provider of infrastructure services operating mainly in the United States and Canada. It provides a wide range of construction services, maintenance, replacement, fabrication and engineering services to a diversified base of customers. The reportable segments are the Utilities segment and the Energy segment. The Utilities segment operates in a range of services, including the installation and maintenance of new and existing natural gas and electric utility distribution and transmission systems, and communication systems. The Energy segment operates in a range of services that include engineering, procurement, and construction, retrofits, highway and bridge construction, demolition, site work, outages, pipeline construction and maintenance, and others.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: